诊断学理论与实践 ›› 2021, Vol. 20 ›› Issue (01): 15-20.doi: 10.16150/j.1671-2870.2021.01.003
沈小雁, 郑捷
收稿日期:2021-02-10
出版日期:2021-02-25
发布日期:2022-06-28
Received:2021-02-10
Online:2021-02-25
Published:2022-06-28
中图分类号:
沈小雁, 郑捷. 2005年至2018年皮肤淋巴瘤WHO-EORTC分类标准的发展与比较[J]. 诊断学理论与实践, 2021, 20(01): 15-20.
表1
2005年与2018年WHO-EORTC的PCL分类的比较
| 2005年版本 | 2018年版本 |
|---|---|
| 皮肤T细胞淋巴瘤 | 皮肤T细胞淋巴瘤 |
| 蕈样肉芽肿 | 蕈样肉芽肿 |
| 蕈样肉芽肿变异型 | 蕈样肉芽肿变异型 |
| 亲毛囊性蕈样肉芽肿 | 亲毛囊性蕈样肉芽肿 |
| 肉芽肿皮肤松弛 | 肉芽肿皮肤松弛 |
| 塞扎里综合征 | 塞扎里综合征 |
| 成人T细胞白血病/淋巴瘤 | 成人T细胞白血病/淋巴瘤 |
| 原发性皮肤CD30+淋巴增生性疾病 | 原发性皮肤CD30+淋巴增生性疾病 |
| 原发性皮肤间变大细胞淋巴瘤 | 原发性皮肤间变大细胞淋巴瘤 |
| 淋巴瘤样丘疹病 a) | 淋巴瘤样丘疹病 a) |
| 皮下脂膜炎样T细胞淋巴瘤 | 皮下脂膜炎样T细胞淋巴瘤 |
| 结外NK/T细胞淋巴瘤,鼻型 | 结外NK/T细胞淋巴瘤,鼻型 |
| 慢性活动性EB病毒感染c) | |
| 原发性皮肤外周T细胞淋巴瘤,未明类型 | 原发性皮肤外周T细胞淋巴瘤,罕见类型 a) |
| 原发性皮肤侵袭性亲表皮细胞性CD8+T细胞淋巴瘤（暂定） | 原发性皮肤侵袭性亲表皮细胞毒性CD8+ T细胞淋巴瘤（暂定） |
| 皮肤γδT细胞淋巴瘤（暂定） | 皮肤γδT细胞淋巴瘤 |
| 原发性皮肤CD4+中小多形T细胞淋巴瘤（暂定） | 原发性皮肤CD4+中小多形T细胞淋巴增生性疾病（暂定）a) |
| 原发性皮肤肢端CD8+T细胞淋巴瘤（暂定）c) | |
| 原发性皮肤外周T细胞淋巴瘤,非特指型c) | |
| 皮肤B细胞淋巴瘤 | 皮肤B细胞淋巴瘤 |
| 原发性皮肤边缘区B细胞淋巴瘤 | 原发性皮肤边缘区B细胞淋巴瘤 a) |
| 原发性皮肤滤泡中心B细胞淋巴瘤 | 原发性皮肤滤泡中心淋巴瘤 |
| 原发性皮肤弥漫大B细胞淋巴瘤,腿型 | 原发性皮肤弥漫大B细胞淋巴瘤,腿型 |
| 原发性皮肤弥漫大B细胞淋巴瘤,其他类型b) | EBV+黏膜皮肤溃疡（暂定）c) |
| 血管内大B细胞淋巴瘤 | 血管内大B细胞淋巴瘤 |
| 血液系统肿瘤前体：CD4+/CD56+血液皮肤肿瘤（母细胞性NK细胞淋巴瘤）b) |
| [1] |
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10):3768-3785.
doi: 10.1182/blood-2004-09-3502 pmid: 15692063 |
| [2] |
Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer[J]. Blood. 1997 Jul 1; 90(1):354-371.
pmid: 9207472 |
| [3] | Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues[M]. Lyon, France: IARC Press, 2001. |
| [4] |
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20):2375-2390.
doi: 10.1182/blood-2016-01-643569 pmid: 26980727 |
| [5] |
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas[J]. Blood, 2019, 133(16):1703-1714.
doi: 10.1182/blood-2018-11-881268 pmid: 30635287 |
| [6] | Tomasini D, Berti E. Subcutaneous panniculitis-like T-cell lymphoma[J]. G Ital Dermatol Venereol, 2013, 148(4):395-411. |
| [7] |
Hodak E, Amitay-Laish I, Atzmony L, et al. New insights into folliculotropic mycosis fungoides (FMF): a single-center experience[J]. J Am Acad Dermatol, 2016, 75(2):347-355.
doi: 10.1016/j.jaad.2016.03.009 URL |
| [8] |
Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project[J]. Blood, 2008, 111(12):5496-5504.
doi: 10.1182/blood-2008-01-134270 pmid: 18385450 |
| [9] |
Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-ne-gative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes[J]. Blood, 2014, 124(9):1473-1480.
doi: 10.1182/blood-2014-04-571091 pmid: 24894770 |
| [10] |
Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas[J]. Blood, 2012, 120(11):2280-2289.
doi: 10.1182/blood-2012-03-419937 pmid: 22855598 |
| [11] |
Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies[J]. Mod Pathol, 2011, 24(4):596-605.
doi: 10.1038/modpathol.2010.225 URL |
| [12] |
Cohen JI, Iwatsuki K, Ko YH, et al. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting[J]. Leuk Lymphoma, 2020, 61(4):808-819.
doi: 10.1080/10428194.2019.1699080 URL |
| [13] | Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research[J]. Hematology Am Soc Hematol Educ Program, 2009:523-531. |
| [14] |
Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma[J]. Blood, 2013, 122(18):3101-3110.
doi: 10.1182/blood-2013-05-502203 pmid: 23982171 |
| [15] |
Hathuc VM, Hristov AC, Smith LB. Primary Cutaneous Acral CD8+ T-Cell Lymphoma[J]. Arch Pathol Lab Med, 2017, 141(11):1469-1475.
doi: 10.5858/arpa.2017-0230-RA URL |
| [16] |
Cetinözman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma[J]. Am J Surg Pathol, 2012, 36(1):109-116.
doi: 10.1097/PAS.0b013e318230df87 pmid: 21989349 |
| [17] |
Deconinck E, Petrella T, Garnache Ottou F. Blastic plasmacytoid dendritic cell neoplasm: clinical presentation and diagnosis[J]. Hematol Oncol Clin North Am, 2020, 34(3):491-500.
doi: 10.1016/j.hoc.2020.01.010 URL |
| [18] |
Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets[J]. Am J Surg Pathol, 2010, 34(12):1830-1841.
doi: 10.1097/PAS.0b013e3181f72835 pmid: 21107089 |
| [19] | Gru AA, Jaffe ES. Cutaneous EBV-related lymphoproli-ferative disorders[J]. Semin Diagn Pathol, 2017, 34(1):60-75. |
| [1] | 冯国伟, 张晓娟, 郭睿, 关哲, 王越. 治疗前18F-FDG PET/CT显像对结外NK/T细胞淋巴瘤的预后判断价值[J]. 诊断学理论与实践, 2021, 20(06): 533-539. |
| [2] | 范春丽, 吴涛, 薛锋, 胡文雪, 王存邦, 白海. MUM1/IRF4阳性弥漫大B细胞淋巴瘤一例治疗报告并文献复习[J]. 诊断学理论与实践, 2021, 20(04): 399-400. |
| [3] | 李芹芹, 金晓龙, 袁菲. 儿童系统性EB病毒阳性T细胞淋巴瘤临床病理分析一例及文献复习[J]. 诊断学理论与实践, 2020, 19(1): 63-68. |
| [4] | 沈文斌, 郭睿, 李彪. 18F-FDG PET/CT代谢参数在NK/T细胞淋巴瘤预后价值的评估[J]. 诊断学理论与实践, 2019, 18(03): 349-352. |
| [5] | 马媛媛, 王燕, 宋琦, 陈克敏, 赵夏, 王黎, 江旭峰, 赵维莅, 严福华. 肺原发性淋巴瘤的CT影像学特点及文献复习[J]. 诊断学理论与实践, 2018, 17(05): 533-537. |
| [6] | 李菁原, 卢兴国. 成熟B细胞淋巴瘤的复杂性与细胞形态学[J]. 诊断学理论与实践, 2017, 16(05): 557-560. |
| [7] | 魏玉珠, 吴涛, 毛军峰, 胡晓燕, 武慧敏, 白海, 王存邦. 以颈椎病变首诊的弥漫大B细胞淋巴瘤一例报道[J]. 诊断学理论与实践, 2017, 16(04): 432-433. |
| [8] | 熊杰, 朱伟嵘, 钱樱, 赵维莅,. 黄芩苷诱导T细胞淋巴瘤凋亡的初步研究[J]. 诊断学理论与实践, 2014, 13(04): 398-402. |
| [9] | 刘之茵, 王文方, 诸江, 李军民,. Blimp1基因突变影响其编码蛋白转录抑制功能的体外研究[J]. 诊断学理论与实践, 2013, 12(02): 194-198. |
| [10] | 董珂, 王鲁群,. 外周T细胞淋巴瘤的细胞和分子遗传学诊断[J]. 诊断学理论与实践, 2013, 12(02): 238-242. |
| [11] | 李倩玉, 奚豪, 韩冬艳, 蒋虹伟, 朱延波,. 灰区淋巴瘤2例临床病理分析[J]. 诊断学理论与实践, 2012, 11(04): 349-353. |
| [12] | 费晓春, 许海敏, 吴华成, 金晓龙,. 蕈样霉菌病24例临床病理分析[J]. 诊断学理论与实践, 2012, 11(04): 361-365. |
| [13] | 王文方, 徐子真, 王爱华, 诸江, 李军民,. 利妥昔单抗和RAD001对弥漫大B细胞株SUDHL-4和DB细胞增殖和凋亡的影响[J]. 诊断学理论与实践, 2012, 11(02): 130-135. |
| [14] | 杨帆, 赵维莅,. 弥漫大B细胞淋巴瘤自噬相关基因表达的初步研究[J]. 诊断学理论与实践, 2012, 11(02): 121-124. |
| [15] | 张正祥, 安晓静, 石群立,. 结外自然杀伤/T细胞淋巴瘤研究进展[J]. 诊断学理论与实践, 2008, 7(06): 677-681. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
